REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) Deferred Tax Assets, Valuation Allowance USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Reviva Pharmaceuticals Holdings, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2019 to 2023.
  • Reviva Pharmaceuticals Holdings, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $27.5 M, a 58.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $27.5 M +$10.2 M +58.7% Dec 31, 2023 10-K 2024-04-15
Q4 2022 $17.3 M +$5.78 M +50.1% Dec 31, 2022 10-K 2024-04-15
Q4 2021 $11.5 M +$2.12 M +22.4% Dec 31, 2021 10-K 2023-03-30
Q4 2020 $9.43 M +$617 K +7% Dec 31, 2020 10-K 2022-03-15
Q4 2019 $8.81 M Dec 31, 2019 10-K/A 2021-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.